Medullospheres from DAOY, UW228 and ONS-76 Cells: Increased Stem Cell Population and Proteomic Modifications

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zanini, Cristina ^a   Ercole, Elisabetta ^a   Mandili, Giorgia ^a   Salaroli, Roberta ^b   Poli, Alice ^c   Renna, Cristiano ^b   Papa, Valentina ^b   Cenacchi, Giovanna ^b   Forni, Marco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c BioDigitalValley Srl ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; NESTIN; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR SOX2; BIOLOGICAL MARKER; PROTEOME;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL MIGRATION; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOFLUOROMETRY; IMMUNOCYTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; UNINDEXED SEQUENCE; CELL MOTION; HUMAN; IMMUNOPHENOTYPING; MASS SPECTROMETRY; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHENOTYPE; PROCEDURES; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TUMOR CELL CULTURE; TUMOR CELL LINE; ULTRASTRUCTURE;

BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; IMMUNOPHENOTYPING; MEDULLOBLASTOMA; NEOPLASTIC STEM CELLS; PHENOTYPE; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84878132993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063748     Document Type: Article

References (37)

1. Giangaspero F, Eberhart CG, Haapsalo H, Pietsch T, Wiestler O, et al. (2007) Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK editors. WHO classification of tumours of central nervous system. IARC Press, Lyon, France. 132-140.
2. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, et al. (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3: e3088.
3. Zanini C, Mandili G, Bertin D, Cerutti F, Baci D, et al. (2011) Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF. Childs Nerv Syst 27: 2077-2085.
4. Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, et al. (2012) Medulloblastoma stem cells: where development and cancer cross pathways. Pediatr Res 71 516-22.
5. Deleyrolle LP, Ericksson G, Morrison BJ, Lopez JA, Burrage K, et al. (2011) Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS One 6: e15844.
6. Read TA, Wechsler-Reya RJ, (2012) Spheres without influence: dissociating in vitro self-renewal from tumorigenic potential in glioma. Cancer Cell 21: 1-3.
7. Castellino RC, De Bortoli M, Lin LL, Skapura DG, Rajan JA, et al. (2007) Overexpressed TP73 induces apoptosis in medulloblastoma. BMC Cancer 7: 127.
8. von Bueren AO, Shalaby T, Oehler-Janne C, Arnold L, Stearns D, et al. (2009) RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer 9: 10 doi:10.1186/1471-2407-9-10.
9. Sun L, Moritake T, Zheng YW, Suzuki K, Gerelchuluun A, et al. (2013) In vitro stemness characterization of radio-resistant clones isolated from a medulloblastoma cell line ONS-76. J Radiat Res 54: 61-69.
10. Ranger A, McDonald W, Moore E, Delmaestro R, (2010) The invasiveness of five medulloblastoma cell lines in collagen gels. J Neurooncol 96: 181-189.
11. Rodini CO, Suzuki DE, Saba-Silva N, Cappellano A, de Souza JE, et al. (2012) Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma. Neurooncol 106: 71-9.
12. Sutter R, Shakhova O, Bhagat H, Behesti H, Sutter C, et al. (2010) Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 29: 1845-1856.
13. Rau R, Brown P, (2009) Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity. Hematol Oncol 27: 171-81.
14. Zanini C, Mandili G, Baci D, Morra I, Forni M, (2010) Proteomic profile modification of anaplastic medulloblastoma after in-vivo radiotherapy: a case study. Journal Cancer Therapy 2: 97-103 doi:10.4236/jct.2010.12017 http://www.scirp.org/journal/jct.
15. Pearson CG, Osborn DP, Giddings TH Jr, Beales PL, Winey M, (2009) Basal body stability and ciliogenesis requires the conserved component Poc1. J Cell Biol 187: 905-920.
16. Santos DM, Xavier JM, Morgado AL, Solá S, Rodrigues CM, (2012) Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation. PLoS ONE 7: e33468.
17. Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, et al. (2012) From cytogenomic to epigenomic profiles: monitoring the biological behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3: 47. [Epub ahead of print].
18. Kyrgidis A, Tzellos TG, Triaridis S, (2010) Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog 9: 3.
19. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010 38: W214-W220.
20. Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, et al. (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482: 529-533.
21. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101: 14228-14233.
22. Knights MJ, Kyle S, Ismail A, (2012) Characteristic features of stem cells in glioblastomas: from cellular biology to genetics. Brain Pathol 22: 592-606.
23. Pastrana E, Silva-Vargas V, Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498. [doi: 10.1016/j.stem.2011.04.007].
24. Lee EK, Cho H, Kim CW, (2011) Proteomic analysis of cancer stem cells in human prostate cancer cells. Biochem Biophys Res Commun 412: 279-285.
25. Peyrl A, Krapfenbauer K, Slavc I, Yang JW, Strobel T, et al. (2003) Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles. Proteomics 3: 1781-1800.
26. Grisendi S, Mecucci C, Falini B, Pandolfi PP, (2006) Nucleophosmin and cancer. Nat Rev Cancer 6: 493-505.
27. Liu Y, Zhang F, Zhang XF, Qi LS, Yang L, et al. (2012) Expression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells. J Biomed Sci19: 53 doi:10.1186/1423-0127-19-53.
28. Kuo MF, Wang HS, Kuo QT, Shun CT, Hsu HC, et al. (2009) High expression of stathmin protein predicts a fulminant course in medulloblastoma. J Neurosurg Pediatr 4: 74-80.
29. Raso A, Negri F, Gregorio A, Nozza P, Mascelli S, et al. (2008) Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma. Neuropathol Appl Neurobiol 34: 306-315.
30. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG, (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177: 1491-1502.
31. Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, et al. (2005) Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res 65: 5607-5619.
32. Burt AD, Smillie D, Cowan MD, Adams FG, (1986) Fine needle aspiration cytology: experience with a cell block technique. J Clin Pathol 39: 114-115.
33. Zanini C, Gerbaudo E, Ercole E, Vendramin A, Forni M, (2012) Evaluation of two commercial and three home-made fixatives for the substitution of formalin: a formaldehyde-free laboratory is possible. Environ. Health. 11: 59 doi:10.1186/1476-069X-11-59.
34. Mandili G, Marini C, Carta F, Zanini C, Prato M, et al. (2011) Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells. PLoS One 6: e18254.
35. Natale M, Bonino D, Consoli P, Alberio T, Ravid RG, et al. (2010) A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1. Bioinformatics 26: 946-952.
36. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. Nov 13(11): 2498-504.
37. Maere S, Heymans K, Kuiper M, (2005) BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21: 3448-3449.